Quintiles Celebrates 10 Years in India with Dedication of New Lab



    
    Mumbai facility expands suite of services offered for global clinical
    trials
    

    RESEARCH TRIANGLE PARK, N.C., April 6 /CNW/ -- Dennis Gillings, CBE,
Chairman and CEO of Quintiles Transnational Corp., today dedicated the
company's new central lab in Mumbai, India, and congratulated Quintiles India
for its 10 years of growth and leadership in clinical research.
    The new lab expands Quintiles' global central laboratory network and
enhances the suite of services offered in India to support global and regional
clinical trials.   In addition to its central lab and clinical research
businesses, Quintiles India offers electrocardiogram (ECG), interactive voice
response (IVR) and data management services.
    "The opening of this new lab in India symbolizes the rapid growth and
achievement of our team here, as well as the acceptance of India as a center
for clinical research," Gillings said.  "Since establishing an office in
Ahmedabad 10 years ago, we have added offices in Mumbai and Bangalore with a
full complement of services, expanded our clinical research staff to 750 and
have conducted more than 700 global trials across business lines.  We also
were involved in the training of hundreds of investigators on Good Clinical
Practice guidelines and helped put India on the world map for clinical
research."
    Ferzaan Engineer, CEO of Quintiles India, said, "The rapid growth of
Quintiles India has been the result of hard work by a dedicated group of
people who are focused on meeting the highest standards for quality and
customer service.  That focus, in turn, has brought more and more global
customers to us, and the need to expand our services, including this new
central lab."
    Tom Wollman, Senior Vice President, Global Central Laboratories, said the
new lab is harmonized with Quintiles' global network. "The India lab has begun
proficiency testing for certification by the College of American Pathologists
(CAP), and we look forward to adding another lab with this well-recognized
global standard of quality to our global footprint."
    The Mumbai lab will provide access to Quintiles laboratory kits, ensure
that all study samples are processed using consistent methods and completed in
a timely manner, and will oversee the data transfer for inclusion in the
Quintiles Laboratory Information Management System and the protocol-specific
database.

    
    About Quintiles Laboratories
    
    Quintiles Laboratories owns a network of clinically harmonized facilities
in the U.S., Europe, South Africa, India, China and Singapore, and has a
tightly controlled network of sub-contractor laboratories in Argentina and
Brazil managed by Quintiles employees located in each of the sub-contractor
facilities.

    
    About Quintiles
    
    Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the biotechnology
and healthcare industries. With 17,000 employees and offices in more than 50
countries, it is focused on providing customer-centric solutions that are the
gold standard of the industry. For more information, please visit the
company's Web site at www.quintiles.com.





For further information:

For further information: Dick Jones, Media Relations, +1-919-998-2091,
or  media.info@quintiles.com, or Greg Connors, Investor Relations, 
+1-919-998-2000, or invest@quintiles.com, both of Quintiles Transnational 
Corp. Web Site: http://www.quintiles.com/

Organization Profile

QUINTILES TRANSNATIONAL CORP.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890